148 related articles for article (PubMed ID: 34491719)
1. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
2. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
[TBL] [Abstract][Full Text] [Related]
3. Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
Jones M; Grosche P; Floersheimer A; André J; Gattlen R; Oser D; Tinchant J; Wille R; Chie-Leon B; Gerspacher M; Ertl P; Ostermann N; Altmann E; Manchado E; Vorherr T; Chène P
Biochemistry; 2023 Apr; 62(7):1321-1329. PubMed ID: 36883372
[TBL] [Abstract][Full Text] [Related]
4. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
[TBL] [Abstract][Full Text] [Related]
5. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
[TBL] [Abstract][Full Text] [Related]
7. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
[TBL] [Abstract][Full Text] [Related]
8. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
9. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
Kasper LH; Boussouar F; Ney PA; Jackson CW; Rehg J; van Deursen JM; Brindle PK
Nature; 2002 Oct; 419(6908):738-43. PubMed ID: 12384703
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
Cook PR; Polakowski N; Lemasson I
J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
[TBL] [Abstract][Full Text] [Related]
12. Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.
Suetaka S; Oka Y; Kunihara T; Hayashi Y; Arai M
Sci Rep; 2022 Jan; 12(1):816. PubMed ID: 35058484
[TBL] [Abstract][Full Text] [Related]
13. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation.
Sano Y; Ishii S
J Biol Chem; 2001 Feb; 276(5):3674-82. PubMed ID: 11073948
[TBL] [Abstract][Full Text] [Related]
14. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.
Yang K; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10040-10045. PubMed ID: 30232260
[TBL] [Abstract][Full Text] [Related]
16. Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.
Korkmaz EN; Nussinov R; Haliloğlu T
PLoS Comput Biol; 2012; 8(3):e1002420. PubMed ID: 22438798
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb.
Zor T; De Guzman RN; Dyson HJ; Wright PE
J Mol Biol; 2004 Mar; 337(3):521-34. PubMed ID: 15019774
[TBL] [Abstract][Full Text] [Related]
18. Experimental and molecular dynamics studies showed that CBP KIX mutation affects the stability of CBP:c-Myb complex.
Odoux A; Jindal D; Tamas TC; Lim BW; Pollard D; Xu W
Comput Biol Chem; 2016 Jun; 62():47-59. PubMed ID: 27082784
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for cooperative transcription factor binding to the CBP coactivator.
De Guzman RN; Goto NK; Dyson HJ; Wright PE
J Mol Biol; 2006 Feb; 355(5):1005-13. PubMed ID: 16253272
[TBL] [Abstract][Full Text] [Related]
20. Binding mode and transcriptional activation potential of high affinity ligands for the CBP KIX domain.
Volkman HM; Rutledge SE; Schepartz A
J Am Chem Soc; 2005 Apr; 127(13):4649-58. PubMed ID: 15796530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
